Reducing huntingtin by immunotherapy delays disease progression in a mouse model of Huntington disease.
Bartl S, Xie Y, Potluri N, Kesineni R, Hencak K, Cengio LD, Balazs K, Oueslati A, Parth M, Salhat N, Siddu A, Smrzka O, Cicchetti F, Straffler G, Hayden MR, Southwell AL.
Bartl S, et al.
Neurobiol Dis. 2024 Jan;190:106376. doi: 10.1016/j.nbd.2023.106376. Epub 2023 Dec 12.
Neurobiol Dis. 2024.
PMID: 38092268
Free article.